(PRESS RELEASE) ANKENY, IO — APC announced the publication of a peer-reviewed study conducted with the University of Illinois Department of Animal Sciences evaluating how plasma included in extruded kibble supports canine gut health and key immune indicators. Gut health is widely recognized as a driver of whole-body wellness through pathways like the gut-brain axis, and this new paper adds to a growing body of evidence on plasma’s role in supporting that system. Results show meaningful shifts in fecal metabolite profiles suggesting a beneficial microbial impact and a positive effect on gut health.
Previous peer-reviewed work in mice has reported reductions in systemic inflammation, neuroprotective properties, and beneficial shifts in intestinal microbiota with plasma. Studies in other species have shown systemic improvements, including patterns that scale with plasma inclusion level. The University of Illinois canine study builds on this foundation to examine microbiome composition and inflammation-related measures under controlled conditions.
“Across species we continue to see a consistent, positive effect on gut health,” said Joy Campbell, Senior Director of Global Pet Food Technical Service at APC. “In this canine study we observed linear effects tied to inclusion level that demonstrate commercial potential in pet foods, functional treats and supplements. We’re excited to see such positive and impactful results from this in species study.”
Research highlights include:
- Study design and controls that isolate plasma’s contribution to gut health
- Exploration of the linear effects of plasma in canine diets
- Nutrient digestibility, fecal metabolites, microbiome and immune biomarker results relevant to canine gut health
The full study, “Effects of spray-dried plasma on nutrient digestibility, fecal metabolites, microbiota, and immune and inflammatory biomarkers in adult dogs,” published in the Journal of Animal Science is now available at: https://academic.oup.com/jas/article-abstract/doi/10.1093/jas/skaf373/8313524. For additional information, visit www.apcpet.com.
About APC
APC is a global leader in the manufacture and sales of blood-derived functional plasma proteins and red blood cell products, impacting billions of animals and plants each year. Founded in 1981, APC’s pioneering research into plasma-derived proteins has resulted in over 600 published journal articles and more than a dozen patents. With 500+ employees and 17 manufacturing facilities across eight countries, APC remains committed to supporting animal health and manufacturing efficiency. Focused on sustainability, APC develops high-performance, environmentally friendly solutions to improve animal health, reduce environmental impact, and create a more sustainable future for the global supply chain.
Advertisement
